Project Diabetes 11.11.11 Ideas
Over at Diabetes 11.11.11, I have started to list some ideas for Project Diabetes 11.11.11. Please go check them out, as there is only 6 days to GO!!! Feel free…
Hospital Social Media Success: Even More Attention Than Expected
Hi Christina, If you don’t mind, I’d like to share a real success story we recently experienced. I continue to enjoy your blog and the insights on Twitter. Keep…
Ranking Health Aid Quality: Worthwhile or Waste?
This is a joint post with Denizhan Duran. This is a joint post with Denizhan Duran. Two months ago, we set out to create an index that measures the quality…
Laparoscopic Hysterectomy: A Surgeon Makes the Case (podcast)
Open surgery is still the most common way to perform a hysterectomy, even though minimally invasive approaches could be used in most cases. In this podcast, Dr. Robert Darrow of…
California Hospital Association Sues HHS
Governor Brown signed a new law that is retro-active to June 1st, and the federal government approved, so does this mean hospitals and doctors will have to pay back payments…
November is National Family Caregiver Month
In 1994, the National Family Caregivers Association (NFCA) began promoting the celebration of family caregivers during the week of Thanksgiving. President Clinton signed the first presidential proclamation in 1997 and…
Will State Health Information Exchanges Cross State Lines?
This is a great article written by Josh Israel and Kimberly Leonard from iWatchNews that addresses the interoperability of state health information exchanges ability to communicate with other states and…
Priority-Setting at WHO
WHO’s Executive Board met last month to review progress on reforms at the agency. Among the documents distributed to the Board, there is a report on plans for priority-setting amongst…
Off-Label Drug Promotion and the First Amendment
Doctors can and often do prescribe medications for different purposes than what the FDA has approved them for. But drug companies face tight restrictions on communicating with physicians about these…
FDA Accepts NDA for VIVUS’ Qnexa
VIVUS, Inc., has announced that the FDA has accepted its new drug application for the company's Qnexa, a phentermine/topiramate combination. The low-dose, oral, controlled-release drug is designed to reduce appetite…
